AB56-SA2,46,1211 1. Maintains a formulary and claims payment system with current information
12on prescription drugs imported under the program.
AB56-SA2,46,1513 2. Bases cost-sharing amounts for participants or insureds under the plan or
14policy on no more than the actual acquisition cost of the prescription drug imported
15under the program that is dispensed to the participant or insured.
AB56-SA2,46,1816 3. Demonstrates to the department or a state agency designated by the
17department how premiums under the policy or plan are affected by savings on
18prescription drugs imported under the program.
AB56-SA2,46,2119 (j) Any wholesale distributor importing prescription drugs under the program
20under this section shall limit its profit margin to the amount established by the
21department or a state agency designated by the department.
AB56-SA2,46,2422 (k) The prescription drug importation program under this section may not
23import any generic prescription drug that would violate federal patent laws on
24branded products in this country.
AB56-SA2,47,5
1(L) The prescription drug importation program under this section shall comply
2to the extent practical and feasible before the prescription drug to be imported comes
3into possession of the state's wholesale distributor and fully after the prescription
4drug to be imported is in possession of the state's wholesale distributor with tracking
5and tracing requirements of 21 USC 360eee to 360eee-1.
AB56-SA2,47,86 (m) The prescription drug importation program under this section shall
7establish a fee or other approach to finance the program that does not jeopardize
8significant savings to residents of the state.
AB56-SA2,47,109 (n) The prescription drug importation program under this section shall have
10an audit function that ensures all of the following:
AB56-SA2,47,1311 1. The department has a sound methodology to determine the most
12cost-effective prescription drugs to include in the importation program under this
13section.
AB56-SA2,47,1514 2. The department has a process in place to select Canadian suppliers that are
15high quality, high performing, and in full compliance with Canadian laws.
AB56-SA2,47,1716 3. Prescription drugs imported under the program are pure, unadulterated,
17potent, and safe.
AB56-SA2,47,1918 4. The prescription drug importation program is complying with the
19requirements of this subsection.
AB56-SA2,47,2220 5. The prescription drug importation program under this section is adequately
21financed to support administrative functions of the program while generating
22significant cost savings to residents of the state.
AB56-SA2,47,2423 6. The prescription drug importation program under this section does not put
24residents of the state at a higher risk than if the program did not exist.
AB56-SA2,48,2
17. The prescription drug importation program under this section provides and
2is projected to continue to provide substantial cost savings to residents of the state.
AB56-SA2,48,5 3(2) Anticompetitive behavior. The department, in consultation with the
4attorney general, shall identify the potential for and monitor anticompetitive
5behavior in industries affected by a prescription drug importation program.
AB56-SA2,48,16 6(3) Approval of program design; certification. No later than the first day of
7the 7th month beginning after the effective date of this subsection .... [LRB inserts
8date], the department shall submit to the joint committee on finance a report that
9includes the design of the prescription drug importation program in accordance with
10this section. The department may not submit the proposed prescription drug
11importation program to the federal department of health and human services unless
12the joint committee on finance approves the proposed prescription drug
13implementation program. Within 14 days of the date of approval by the joint
14committee on finance of the proposed prescription drug importation program, the
15department shall submit to the federal department of health and human services a
16request for certification of the approved prescription drug importation program.
AB56-SA2,48,24 17(4) Implementation of certified program. After the federal department of
18health and human services certifies the prescription drug importation program
19submitted under sub. (3), the department shall begin implementation of the program
20and the program shall be fully operational by 180 days after the date of certification
21by the federal department of health and human services. The department shall do
22all of the following to implement the prescription drug importation program to the
23extent the action is in accordance with other state laws and the certification by the
24federal department of health and human services:
AB56-SA2,49,3
1(a) Become a licensed wholesale distributor, designate another state agency to
2become a licensed wholesale distributor, or contract with a licensed wholesale
3distributor.
AB56-SA2,49,54 (b) Contract with one or more Canadian suppliers that meet the criteria in sub.
5(1) (c).
AB56-SA2,49,96 (c) Create an outreach and marketing plan to communicate with and provide
7information to health plans and health insurance policies, employers, pharmacies,
8health care providers, and residents of the state on participating in the prescription
9drug importation program.
AB56-SA2,49,1210 (d) Develop and implement a registration process for health plans and health
11insurance policies, pharmacies, and health care providers interested in participating
12in the prescription drug importation program.
AB56-SA2,49,1413 (e) Create a publicly accessible source for listing prices of prescription drugs
14imported under the program.
AB56-SA2,49,1715 (f) Create, publicize, and implement a method of communication to promptly
16answer questions from and address the needs of persons affected by the
17implementation of the program before the program is fully operational.
AB56-SA2,49,1918 (g) Establish the audit functions under sub. (1) (n) with a timeline to complete
19each audit function every 2 years.
AB56-SA2,49,2220 (h) Conduct any other activities determined by the department to be important
21to successful implementation of the prescription drug importation program under
22this section.
AB56-SA2,49,24 23(5) Report. By January 1 and July 1 of each year, the department shall submit
24to the joint committee on finance a report including all of the following:
AB56-SA2,50,2
1(a) A list of prescription drugs included in the importation program under this
2section.
AB56-SA2,50,53 (b) The number of pharmacies, health care providers, and health plans and
4health insurance policies participating in the prescription drug importation program
5under this section.